Micki Klearman
Directeur/Bestuurslid bij KEZAR LIFE SCIENCES, INC.
Vermogen: - $ op 30-04-2024
Profiel
Micki Klearman is an Independent Director at Kezar Life Sciences, Inc. He previously worked at Genentech, Inc. as an Associate Group Medical Director-Immunology from 2007 to 2018.
He received his undergraduate degree from Stanford University and his doctorate from Washington University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
KEZAR LIFE SCIENCES INC
-.--% | 01-04-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Micki Klearman
| Bedrijven | Functie | Begin |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Directeur/Bestuurslid | 01-06-2021 |
Eerdere bekende functies van Micki Klearman
| Bedrijven | Functie | Einde |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-01-2018 |
Opleiding van Micki Klearman
| Washington University School of Medicine | Doctorate Degree |
| Stanford University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
